Shareholders sell 8.4% stake in Egypt’s Ibnsina Pharma
Shareholders sell 8.4% stake in Ibnsina: Shareholders have sold 8.4% of their shares in Ibnsina Pharma, amounting to around 69.1…
Available in your choice of English or Arabic
Shareholders sell 8.4% stake in Ibnsina: Shareholders have sold 8.4% of their shares in Ibnsina Pharma, amounting to around 69.1…
Ibnsina Pharma has signed an agreement with global pharma company Roche to import and distribute 40 Roche products in Egypt,…
Future Pharma is planning to invest USD 3 mn to set up three new production lines, two of which are…
DISPUTE WATCH- Health Ministry permanently suspends El Ezaby, Roshdy from pharmacy registry: A Health Ministry body has permanently removed pharmacists…
EARNINGS WATCH- Ibnsina Pharma’s 2Q2019 profits surge 26% y-o-y: Ibnsina Pharma reported a 26% y-o-y increase in consolidated net profits…
We need to get companies investing in antibiotics: The growing phenomenon of antibiotic resistance is rendering the most common antibiotics…
INVESTMENT WATCH- EFG Hermes to invest USD 60 mn in education, pharma acquisitions: EFG Hermes is set to acquire schools…
LEGISLATION WATCH- EDA’s mandate expands under new pharma legislation: The Health Ministry will transfer regulatory powers over the pharma market…
Something went wrong. Please refresh the page and/or try again.
Queue